Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi to Buy Biogen Hemophilia Spinoff for $11.6 Billion
Bloomberg
Mon, 01/22/18 - 11:05 am
Tags:
Sanofi, M&A, Bioverativ, Biogen, hemophilia
Sanofi near deal to buy Bioverativ for more than $11.5 bln -WSJ
Yahoo/Reuters
Sun, 01/21/18 - 09:07 pm
Tags:
Sanofi, M&A, Bioverativ
[forum discussion] Seriously, can somebody tell us what is going on!!
Cafepharma Message Boards
Thu, 01/18/18 - 06:11 pm
Tags:
Sanofi
Closing JPM18: Winners and losers, brighter days for neuroscience
Biopharma Dive
Sat, 01/13/18 - 10:58 pm
Tags:
JPMHC 2018, Neurosciences, China, Sanofi, tax reform, GSK, Biogen, Celgene, channel stuffing
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Fierce Pharma
Thu, 01/11/18 - 11:44 pm
Tags:
Sanofi, Europe, generics, China, India
Sanofi and Regeneron's Dupixent launch is about to get a cash infusion
Fierce Pharma
Wed, 01/10/18 - 10:07 am
Tags:
Sanofi, Regeneron, Dupixent, drug launches, eczema, JPMHC 2018
JPM18: Regeneron, Sanofi boost I/O investment
Biopharma Dive
Mon, 01/8/18 - 10:02 pm
Tags:
Regeneron, Sanofi, immuno-oncology, JPMHC 2018
Alnylam kicks off #JPM18 with a restructured Sanofi deal, grabbing global rights to patisiran
Endpoints
Mon, 01/8/18 - 09:45 am
Tags:
Alnylam, Sanofi, JPMHC 2018, Patisiran
Sanofi and Regeneron boost investment in cancer drug cemiplimab
Yahoo/Reuters
Mon, 01/8/18 - 09:43 am
Tags:
Sanofi, Regeneron, cemiplimab, cancer, dupilumab
Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report
Fierce Pharma
Tue, 01/2/18 - 07:21 pm
Tags:
Pfizer, Valneva, Sanofi, C. difficile, vaccines, PF-06425090
Alnylam, Sanofi given the all-clear to resume fitusiran trials
BioPharma Dive
Sun, 12/17/17 - 10:24 am
Tags:
Alnylam, Sanofi, clinical trials, fitusiran, hemophilia
Mylan Announces IPR Proceedings for Sanofi's Lantus Patents
Yahoo/Zacks.com
Fri, 12/15/17 - 11:45 pm
Tags:
Mylan Labs, inter partes review, Sanofi, Lantus, patents, diabetes
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
Motley Fool
Wed, 12/13/17 - 11:01 pm
Tags:
Regeneron, Sanofi, cemiplimab, skin cancer
Regeneron, Sanofi are ready to debut the 6th PD-1/L1. Is it still possible to stand out from the growing crowd?
Endpoints
Wed, 12/13/17 - 09:44 am
Tags:
Regeneron, Sanofi, anti-PD-L1, cemiplimab, advanced cutaneous squamous cell carcinoma
Sanofi investors hungry for drug progress and deal news
Reuters
Tue, 12/12/17 - 10:52 pm
Tags:
Sanofi, investors, innovation
Sanofi’s R&D day poses some big challenges as skeptics circle in wake of a Dengvaxia fiasco
Endpoints
Tue, 12/12/17 - 10:12 am
Tags:
Sanofi, R&D, vaccines, Dengvaxia
FDA approves Sanofi’s short-acting insulin lispro injection
Drug Delivery Business News
Mon, 12/11/17 - 11:22 pm
Tags:
FDA, Sanofi, insulin, Admelog insulin lispro, diabetes
Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines
Stat
Mon, 12/11/17 - 09:56 am
Tags:
Sanofi, vaccines, dengue, Philiphines
Philippines wants money back from Sanofi for dengue vaccine
Yahoo/AP
Fri, 12/8/17 - 10:06 am
Tags:
Sanofi, Philippines, dengue, vaccines
J&J, Sanofi ranked best for clinical trial transparency
BioPharma Dive
Wed, 12/6/17 - 09:43 am
Tags:
JNJ, Sanofi, clinical trials, transparency, clinical trial data

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.